BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jones EA, Bergasa NV. The pruritus of cholestasis. Hepatology. 1999;29:1003-1006. [PMID: 10094938 DOI: 10.1002/hep.510290450] [Cited by in Crossref: 117] [Cited by in F6Publishing: 91] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Umeuchi H, Togashi Y, Honda T, Nakao K, Okano K, Tanaka T, Nagase H. Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system. Eur J Pharmacol. 2003;477:29-35. [PMID: 14512095 DOI: 10.1016/j.ejphar.2003.08.007] [Cited by in Crossref: 99] [Cited by in F6Publishing: 76] [Article Influence: 5.5] [Reference Citation Analysis]
2 Marzioni M, Svegliati Baroni G, Alpini G, Benedetti A. Endogenous opioid peptides and chronic liver disease: from bedside to bench. J Hepatol 2007;46:583-6. [PMID: 17313989 DOI: 10.1016/j.jhep.2007.01.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
3 Tajiri K, Shimizu Y. Recent advances in the management of pruritus in chronic liver diseases. World J Gastroenterol 2017; 23(19): 3418-3426 [PMID: 28596678 DOI: 10.3748/wjg.v23.i19.3418] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
4 Kim HJ, Park JB, Lee JH, Kim I. How stress triggers itch: a preliminary study of the mechanism of stress-induced pruritus using fMRI. Int J Dermatol 2016;55:434-42. [DOI: 10.1111/ijd.12864] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
5 Newton JL, Bhala N, Burt J, Jones DE. Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure. Journal of Hepatology 2006;44:776-83. [DOI: 10.1016/j.jhep.2005.12.012] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 4.8] [Reference Citation Analysis]
6 Kaur R, Sinha V. Antidepressants as antipruritic agents: A review. European Neuropsychopharmacology 2018;28:341-52. [DOI: 10.1016/j.euroneuro.2018.01.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Yosipovitch G. Pruritus. Current Problems in Dermatology 2003;15:143-64. [DOI: 10.1016/s1040-0486(03)00017-6] [Cited by in Crossref: 14] [Article Influence: 0.7] [Reference Citation Analysis]
8 Ghent CN. The pruritus of cholestasis. Hepatology 1999;30:586-7. [DOI: 10.1002/hep.510300228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
9 Glasova H, Beuers U. Extrahepatic manifestations of cholestasis. Journal of Gastroenterology and Hepatology 2002;17:938-48. [DOI: 10.1046/j.1440-1746.2002.02717.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
10 Cies JJ, Giamalis JN. Treatment of cholestatic pruritus in children. American Journal of Health-System Pharmacy 2007;64:1157-62. [DOI: 10.2146/ajhp060453] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
11 Jones EA. Pruritus and fatigue associated with liver disease: is there a role for ondansetron? Expert Opinion on Pharmacotherapy 2008;9:645-51. [DOI: 10.1517/14656566.9.4.645] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
12 Riazi K, Honar H, Homayoun H, Demehri S, Bahadori M, Dehpour AR. Intestinal inflammation alters the susceptibility to pentylenetetrazole-induced seizure in mice. J Gastroenterol Hepatol 2004;19:270-7. [PMID: 14748873 DOI: 10.1111/j.1440-1746.2003.03284.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
13 Etter L, Myers SA. Pruritus in systemic disease: mechanisms and management. Dermatologic Clinics 2002;20:459-72. [DOI: 10.1016/s0733-8635(02)00011-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
14 Browning J, Combes B, Mayo MJ. Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol. 2003;98:2736-2741. [PMID: 14687826 DOI: 10.1111/j.1572-0241.2003.08662.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 59] [Article Influence: 4.8] [Reference Citation Analysis]
15 Marzioni M, Alpini G, Saccomanno S, de Minicis S, Glaser S, Francis H, Trozzi L, Venter J, Orlando F, Fava G, Candelaresi C, Macarri G, Benedetti A. Endogenous Opioids Modulate the Growth of the Biliary Tree in the Course of Cholestasis. Gastroenterology 2006;130:1831-47. [DOI: 10.1053/j.gastro.2006.02.021] [Cited by in Crossref: 32] [Cited by in F6Publishing: 77] [Article Influence: 2.0] [Reference Citation Analysis]
16 Kremer AE, Oude Elferink RP, Beuers U. Cholestatic pruritus: new insights into pathophysiology and current treatment. Hautarzt. 2012;63:532-538. [PMID: 22733242 DOI: 10.1007/s00105-011-2321-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
17 Siemens W, Xander C, Meerpohl JJ, Buroh S, Antes G, Schwarzer G, Becker G. Pharmacological interventions for pruritus in adult palliative care patients. Cochrane Database Syst Rev 2016;11:CD008320. [PMID: 27849111 DOI: 10.1002/14651858.CD008320.pub3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
18 Greaves MW. Itch in systemic disease: therapeutic options: Itch in systemic disease. Dermatologic Therapy 2005;18:323-7. [DOI: 10.1111/j.1529-8019.2005.00036.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
19 Song J, Xian D, Yang L, Xiong X, Lai R, Zhong J. Pruritus: Progress toward Pathogenesis and Treatment. Biomed Res Int 2018;2018:9625936. [PMID: 29850592 DOI: 10.1155/2018/9625936] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
20 Silveira MG, Gossard AA, Stahler AC, Jorgensen RA, Petz JL, Ali AH, Lindor KD. A Randomized, Placebo-Controlled Clinical Trial of Efficacy and Safety: Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis. Am J Ther. 2016; Epub ahead of print. [PMID: 27148676 DOI: 10.1097/mjt.0000000000000387] [Cited by in Crossref: 25] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
21 Bergasa NV, McGee M, Ginsburg IH, Engler D. Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial. Hepatology. 2006;44:1317-1323. [PMID: 17058231 DOI: 10.1002/hep.21370] [Cited by in Crossref: 69] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
22 Jones EA. Altered central serotoninergic neurotransmission: a potential mechanism for profound fatigue complicating chronic hepatitis C. Med Hypotheses. 2001;57:133-134. [PMID: 11461159 DOI: 10.1054/mehy.2000.1287] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
23 Elferink RO. Cholestasis. Gut. 2003;52 Suppl 2:ii42-ii48. [PMID: 12651881 DOI: 10.1136/gut.52.suppl_2.ii42] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
24 McRae CA, Prince MI, Hudson M, Day CP, James OF, Jones DE. Pain as a complication of use of opiate antagonists for symptom control in cholestasis. Gastroenterology 2003;125:591-6. [PMID: 12891561 DOI: 10.1016/s0016-5085(03)00879-5] [Cited by in Crossref: 55] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
25 Kunzmann S, Kullak-ublick GA, Greiner A, Jeschke R, Hebestreit H. Effective Opiate-Receptor Antagonist Therapy of Cholestatic Pruritus Induced by an Oral Contraceptive: . Journal of Pediatric Gastroenterology and Nutrition 2005;40:596-9. [DOI: 10.1097/01.mpg.0000148775.64966.96] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Zellos A, Roy A, Schwarz KB. Use of oral naltrexone for severe pruritus due to cholestatic liver disease in children. J Pediatr Gastroenterol Nutr 2010;51:787-9. [PMID: 20948447 DOI: 10.1097/MPG.0b013e3181eb5ac0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
27 Roosterman D, Goerge T, Schneider SW, Bunnett NW, Steinhoff M. Neuronal Control of Skin Function: The Skin as a Neuroimmunoendocrine Organ. Physiological Reviews 2006;86:1309-79. [DOI: 10.1152/physrev.00026.2005] [Cited by in Crossref: 359] [Cited by in F6Publishing: 299] [Article Influence: 22.4] [Reference Citation Analysis]
28 Vaccarino AL, Kastin AJ. Endogenous opiates: 1999. Peptides. 2000;21:1975-2034. [PMID: 11150656 DOI: 10.1016/S0196-9781(00)00345-4] [Cited by in Crossref: 53] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
29 Anand S. Gabapentin for Pruritus in Palliative care. Am J Hosp Palliat Care 2013;30:192-6. [DOI: 10.1177/1049909112445464] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
30 Pusl T, Beuers U. Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy. Clin Rev Allergy Immunol. 2005;28:147-157. [PMID: 15879620 DOI: 10.1385/criai:28:2:147] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
31 Bergasa NV, Jones EA. Assessment of the Visual Analogue Score in the Evaluation of the Pruritus of Cholestasis. J Clin Transl Hepatol 2017;5:203-7. [PMID: 28936401 DOI: 10.14218/JCTH.2017.00001] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
32 Fujino H, Tanaka M, Imamura M, Morio K, Ono A, Nakahara T, Murakami E, Kawaoka T, Takahashi S, Miki D, Tsuge M, Hiramatsu A, Aikata H, Hayes CN, Chayama K. Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis. BMC Gastroenterol 2019;19:169. [PMID: 31651244 DOI: 10.1186/s12876-019-1092-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
33 Marzioni M, Saccomanno S, Candelaresi C, Rychlicki C, Agostinelli L, Trozzi L, De Minicis S, Benedetti A. Clinical implications of novel aspects of biliary pathophysiology. Dig Liver Dis 2010;42:238-44. [PMID: 20167547 DOI: 10.1016/j.dld.2010.01.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
34 Culver EL, Chapman RW. Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis. Aliment Pharmacol Ther. 2011;33:1273-1291. [PMID: 21501198 DOI: 10.1111/j.1365-2036.2011.04658.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
35 Ostadhadi S, Haddadi N, Foroutan A, Azimi E, Elmariah S, Dehpour A. Development of resistance to serotonin-induced itch in bile duct ligated mice. Clin Exp Pharmacol Physiol 2017;44:680-5. [DOI: 10.1111/1440-1681.12752] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
36 Hegade VS, Bolier R, Oude Elferink RP, Beuers U, Kendrick S, Jones DE. A systematic approach to the management of cholestatic pruritus in primary biliary cirrhosis. Frontline Gastroenterol 2016;7:158-66. [PMID: 28839853 DOI: 10.1136/flgastro-2015-100618] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
37 Davis MP, Frandsen JL, Walsh D, Andresen S, Taylor S. Mirtazapine for Pruritus. Journal of Pain and Symptom Management 2003;25:288-91. [DOI: 10.1016/s0885-3924(02)00645-0] [Cited by in Crossref: 127] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
38 Sun Y, Zhang W, Evans JF, Floreani A, Zou Z, Nishio Y, Qi R, Leung PS, Bowlus CL, Gershwin ME. Autotaxin, Pruritus and Primary Biliary Cholangitis (PBC). Autoimmun Rev. 2016;15:795-800. [PMID: 27019050 DOI: 10.1016/j.autrev.2016.03.019] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
39 Memtsa M, Pun S, West P, Okolo S, Yoong W. Consensus on the management of obstetric cholestasis: national UK survey. BJOG 2007;114:910-1. [PMID: 17567430 DOI: 10.1111/j.1471-0528.2007.01380.x] [Reference Citation Analysis]
40 Kremer AE, Feramisco J, Reeh PW, Beuers U, Oude Elferink RP. Receptors, cells and circuits involved in pruritus of systemic disorders. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2014;1842:869-92. [DOI: 10.1016/j.bbadis.2014.02.007] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
41 Gay M, Pares A, Carrascal M, Bosch-i-Crespo P, Gorga M, Mas A, Abian J. Proteomic analysis of polypeptides captured from blood during extracorporeal albumin dialysis in patients with cholestasis and resistant pruritus. PLoS One 2011;6:e21850. [PMID: 21779339 DOI: 10.1371/journal.pone.0021850] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
42 Samur S, Klebanoff M, Banken R, Pratt DS, Chapman R, Ollendorf DA, Loos AM, Corey K, Hur C, Chhatwal J. Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis. Hepatology. 2017;65:920-928. [PMID: 27906472 DOI: 10.1002/hep.28932] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 10.4] [Reference Citation Analysis]
43 Shorbagi A, Bayraktar Y. Primary sclerosing cholangitis--what is the difference between east and west? World J Gastroenterol. 2008;14:3974-3981. [PMID: 18609680 DOI: 10.3748/wig.3974] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Trauner M, Boyer JL. Cholestatic syndromes. Curr Opin Gastroenterol 2000;16:239-50. [PMID: 17023881 DOI: 10.1097/00001574-200005000-00006] [Reference Citation Analysis]
45 Kenyon AP, Nelson Piercy C, Girling J, Williamson C, Tribe R, Shennan A. Pruritus may precede abnormal liver function tests in pregnant women with obstetric cholestasis: a longitudinal analysis. British Journal of Obstetrics and Gynaecology 2001;108:1190-2. [DOI: 10.1016/s0306-5456(01)00281-9] [Cited by in Crossref: 12] [Article Influence: 0.6] [Reference Citation Analysis]
46 Pusl T, Beuers U. Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy. Clin Rev Allergy Immunol. 2005;28:147-157. [PMID: 15879620 DOI: 10.1385/criai:] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Zakharia K, Tabibian A, Lindor KD, Tabibian JH. Complications, symptoms, quality of life and pregnancy in cholestatic liver disease. Liver Int. 2018;38:399-411. [PMID: 28921801 DOI: 10.1111/liv.13591] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
48 Lidstone V, Thorns A. Pruritus in cancer patients. Cancer Treatment Reviews 2001;27:305-12. [DOI: 10.1053/ctrv.2001.0231] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
49 Jones DE. Complications of Cholestasis. Medicine 2002;30:67-8. [DOI: 10.1383/medc.30.12.67.28521] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
50 Zylicz Z, Krajnik M. What has dry cough in common with pruritus? treatment of dry cough with paroxetine. Journal of Pain and Symptom Management 2004;27:180-4. [DOI: 10.1016/j.jpainsymman.2003.06.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
51 Jones EA, Dekker LR. Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis. Gastroenterology 2000;118:431-2. [PMID: 10648471 DOI: 10.1016/s0016-5085(00)70225-3] [Cited by in Crossref: 53] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
52 Lonsdale-eccles A, Carmichael AJ. Treatment of Pruritus Associated with Systemic Disorders in the Elderly: A Review of the Role of New Therapies. Drugs & Aging 2003;20:197-208. [DOI: 10.2165/00002512-200320030-00004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
53 Bergasa NV, Rothman RB, Mukerjee E, Vergalla J, Jones EA. Up-regulation of central mu-opioid receptors in a model of hepatic encephalopathy: a potential mechanism for increased sensitivity to morphine in liver failure. Life Sci 2002;70:1701-8. [PMID: 11991257 DOI: 10.1016/s0024-3205(02)01487-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
54 Neuberger J, Jones EA. Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy. Eur J Gastroenterol Hepatol. 2001;13:1393-1394. [PMID: 11692070 DOI: 10.1097/00042737-200111000-00022] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
55 Szarvas S, Harmon D, Murphy D. Neuraxial opioid-induced pruritus: a review. Journal of Clinical Anesthesia 2003;15:234-9. [DOI: 10.1016/s0952-8180(02)00501-9] [Cited by in Crossref: 122] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
56 Kenyon AP, Piercy CN, Girling J, Williamson C, Tribe RM, Shennan AH. Pruritus may precede abnormal liver function tests in pregnant women with obstetric cholestasis: a longitudinal analysis. BJOG 2001;108:1190-2. [PMID: 11762661 DOI: 10.1111/j.1471-0528.2003.00281.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 0.2] [Reference Citation Analysis]
57 Malik A, Kardashian AA, Zakharia K, Bowlus CL, Tabibian JH. Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist. Liver Res 2019;3:118-27. [PMID: 32042471 DOI: 10.1016/j.livres.2019.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
58 Villamil AG, Bandi JC, Galdame OA, Gerona S, Gadano AC. Efficacy of lidocaine in the treatment of pruritus in patients with chronic cholestatic liver diseases. Am J Med. 2005;118:1160-1163. [PMID: 16194649 DOI: 10.1016/j.amjmed.2005.05.031] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
59 Day SA, Lakner AM, Moore CC, Yen MH, Clemens MG, Wu ES, Schrum LW. Opioid-like compound exerts anti-fibrotic activity via decreased hepatic stellate cell activation and inflammation. Biochem Pharmacol. 2011;81:996-1003. [PMID: 21291870 DOI: 10.1016/j.bcp.2011.01.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
60 Kremer AE, Oude Elferink RP, Beuers U. Pathophysiology and current management of pruritus in liver disease. Clin Res Hepatol Gastroenterol. 2011;35:89-97. [PMID: 21809485 DOI: 10.1016/j.clinre.2010.10.007] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
61 Fawaz B, Chamseddin BH, Griffin JR. Defining the role of mirtazapine in the treatment of refractory pruritus. J Dermatolog Treat 2021;32:132-6. [PMID: 31180795 DOI: 10.1080/09546634.2019.1630702] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
62 Carbajo Ferreira A, Manzanares López-manzanares J. Tratamiento médico y soporte nutricional del paciente con enfermedad colestática crónica. Anales de Pediatría 2003;58:174-80. [DOI: 10.1016/s1695-4033(03)78022-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
63 Carrion AF, Rosen JD, Levy C. Understanding and Treating Pruritus in Primary Biliary Cholangitis. Clinics in Liver Disease 2018;22:517-32. [DOI: 10.1016/j.cld.2018.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
64 Singh V, Bhalla A, Sharma N, Dheerendra P, Agarwal R, Mahi S. Nasobiliary drainage in acute cholestatic hepatitis with pruritus. Digestive and Liver Disease 2009;41:442-5. [DOI: 10.1016/j.dld.2008.06.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
65 Lee WK, Yu ZH, Lee CC. Delayed neurological sequelae after carbon monoxide poisoning. Aust N Z J Psychiatry 2008;42:430. [PMID: 18473261 DOI: 10.1080/00048670801961198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
66 Jones E. Trials of opiate antagonists for the pruritus of cholestasis: primary efficacy endpoints and opioid withdrawal-like reactions. Journal of Hepatology 2002;37:863-5. [DOI: 10.1016/s0168-8278(02)00347-1] [Cited by in Crossref: 11] [Article Influence: 0.6] [Reference Citation Analysis]
67 Xander C, Meerpohl JJ, Galandi D, Buroh S, Schwarzer G, Antes G, Becker G. Pharmacological interventions for pruritus in adult palliative care patients. Cochrane Database Syst Rev 2013;:CD008320. [PMID: 23749733 DOI: 10.1002/14651858.CD008320.pub2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
68 Kamimura K, Yokoo T, Kamimura H, Sakamaki A, Abe S, Tsuchiya A, Takamura M, Kawai H, Yamagiwa S, Terai S. Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses. PLoS One. 2017;12:e0178991. [PMID: 28604788 DOI: 10.1371/journal.pone.0178991] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
69 Marzioni M, Fava G, Alvaro D, Alpini G, Benedetti A. Control of cholangiocyte adaptive responses by visceral hormones and neuropeptides. Clin Rev Allergy Immunol. 2009;36:13-22. [PMID: 18548352 DOI: 10.1007/s12016-008-8090-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
70 O’Keeffe C, Baird AW, Nolan N, McCormick PA. Cholestatic pruritus - the role of cutaneous mast cells and nerves. Aliment Pharmacol Ther. 2004;19:1293-1300. [PMID: 15191511 DOI: 10.1111/j.1365-2036.2004.01997.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
71 Oude Elferink R, Groen AK. Genetic defects in hepatobiliary transport. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2002;1586:129-45. [DOI: 10.1016/s0925-4439(01)00103-x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
72 Ahmadi S, Karami Z, Mohammadian A, Khosrobakhsh F, Rostamzadeh J. Cholestasis induced antinociception and decreased gene expression of MOR1 in rat brain. Neuroscience 2015;284:78-86. [DOI: 10.1016/j.neuroscience.2014.08.063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
73 Eisendle K, Müller H, Ortner E, Talasz H, Graziadei I, Vogel W, Höpfl R. Pruritus of unknown origin and elevated total serum bile acid levels in patients without clinically apparent liver disease. J Gastroenterol Hepatol. 2011;26:716-721. [PMID: 21155876 DOI: 10.1111/j.1440-1746.2010.06522.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
74 Shorbagi A, Bayraktar Y. Primary sclerosing cholangitis - What is the difference between east and west? World J Gastroenterol 2008; 14(25): 3974-3981 [PMID: 18609680 DOI: 10.3748/wjg.14.3974] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
75 Cunha PR, Delfini Filho O. Pruritus: still a challenge. An Bras Dermatol 2012;87:735-41. [PMID: 23044567 DOI: 10.1590/s0365-05962012000500011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
76 Lammert F, Marschall H, Matern S. Intrahepatic cholestasis of pregnancy. Curr Treat Options Gastro 2003;6:123-32. [DOI: 10.1007/s11938-003-0013-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
77 Kumada H, Miyakawa H, Muramatsu T, Ando N, Oh T, Takamori K, Nakamoto H. Efficacy of nalfurafine hydrochloride in patients with chronic liver disease with refractory pruritus: A randomized, double-blind trial. Hepatol Res. 2017;47:972-982. [PMID: 27753159 DOI: 10.1111/hepr.12830] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 8.2] [Reference Citation Analysis]
78 Kremer AE, Beuers U, Oude-Elferink RP, Pusl T. Pathogenesis and treatment of pruritus in cholestasis. Drugs. 2008;68:2163-2182. [PMID: 18840005 DOI: 10.2165/00003495-200868150-00006] [Cited by in Crossref: 77] [Cited by in F6Publishing: 58] [Article Influence: 5.9] [Reference Citation Analysis]
79 Terg R, Coronel E, Sordá J, Muñoz AE, Findor J. Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study. J Hepatol 2002;37:717-22. [PMID: 12445410 DOI: 10.1016/s0168-8278(02)00318-5] [Cited by in Crossref: 113] [Cited by in F6Publishing: 22] [Article Influence: 5.9] [Reference Citation Analysis]
80 Braun-falco O, Plewig G, Wolff HH, Burgdorf WHC. Pruritus, Prurigo, Self-Induced Disease, Psychiatric Disease and Neurologic Disease. Dermatology. Berlin: Springer Berlin Heidelberg; 2000. pp. 989-1011. [DOI: 10.1007/978-3-642-97931-6_25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
81 Krajnik M, Zylicz Z. Understanding Pruritus in Systemic Disease. Journal of Pain and Symptom Management 2001;21:151-68. [DOI: 10.1016/s0885-3924(00)00256-6] [Cited by in Crossref: 91] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
82 Jones E, Zylicz Z. Treatment of Pruritus Caused by Cholestasis with Opioid Antagonists. Journal of Palliative Medicine 2005;8:1290-4. [DOI: 10.1089/jpm.2005.8.1290] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
83 Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet. 2003;361:690-694. [PMID: 12606187 DOI: 10.1016/s0140-6736(03)12570-6] [Cited by in Crossref: 299] [Cited by in F6Publishing: 72] [Article Influence: 15.7] [Reference Citation Analysis]
84 Ali AH, Carey EJ, Lindor KD. Diagnosis and management of primary biliary cirrhosis. Expert Review of Clinical Immunology 2014;10:1667-78. [DOI: 10.1586/1744666x.2014.979792] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
85 Mansour-Ghanaei F, Taheri A, Froutan H, Ghofrani H, Nasiri-Toosi M, Bagherzadeh AH, Farahvash MJ, Mirmomen S, Ebrahimi-Dariani N, Farhangi E, Pourrasouli Z. Effect of oral naltrexone on pruritus in cholestatic patients. World J Gastroenterol 2006; 12(7): 1125-1128 [PMID: 16534857 DOI: 10.3748/wjg.v12.i7.1125] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
86 Yokomori H, Oda M, Ishii H. Effects of ursodeoxycholic acid and colestilan versus ursodeoxycholic acid alone on serum bile acids and pruritus: a randomized, open-label study. Current Therapeutic Research 2001;62:221-9. [DOI: 10.1016/s0011-393x(01)80033-3] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
87 Jones DE. Pathogenesis of cholestatic itch: Old questions, new answers, and future opportunities. Hepatology 2012;56:1194-6. [DOI: 10.1002/hep.25847] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
88 Houts CR, Morlock R, Blum SI, Edwards MC, Wirth RJ. Scale development with small samples: a new application of longitudinal item response theory. Qual Life Res 2018;27:1721-34. [PMID: 29423756 DOI: 10.1007/s11136-018-1801-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
89 Silveira MG, Lindor KD. Clinical features and management of primary sclerosing cholangitis. World J Gastroenterol 2008; 14(21): 3338-3349 [PMID: 18528931 DOI: 10.3748/wjg.14.3338] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
90 Dyson JK, Webb G, Hirschfield GM, Lohse A, Beuers U, Lindor K, Jones DE. Unmet clinical need in autoimmune liver diseases. J Hepatol. 2015;62:208-218. [PMID: 25234946 DOI: 10.1016/j.jhep.2014.09.010] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
91 Schmelz M. A neural pathway for itch. Nat Neurosci. 2001;4:9-10. [PMID: 11135635 DOI: 10.1038/82956] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 3.8] [Reference Citation Analysis]
92 Lammert F, Marschall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol. 2000;33:1012-1021. [PMID: 11131439 DOI: 10.1016/s0168-8278(00)80139-7] [Cited by in Crossref: 274] [Cited by in F6Publishing: 65] [Article Influence: 13.0] [Reference Citation Analysis]
93 Small A, Larusso N, Lazaridis K. Primary Sclerosing Cholangitis. Surgery of the Liver, Biliary Tract and Pancreas. Elsevier; 2007. pp. 613-27. [DOI: 10.1016/b978-1-4160-3256-4.50052-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]